PLRXPliant Therapeutics, Inc.

$82M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+178.9% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$30M-594.1% margin

Net Income

-$30M-592.2% margin

EPS (Diluted)

$-0.82

QoQ Revenue Growth

+299.4%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$185M

Total Liabilities

$37M

Stockholders' Equity

$148M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+178.9%
Gross Profit	$5M	$2M	+178.9%
Operating Income	-$30M	-$23M	-29.4%
Net Income	-$30M	-$23M	-29.4%

PLRX Q2 2022 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena